Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Duoduo Pharmaceutical, officially known as Heilongjiang Duoduo Pharmaceutical Co., Ltd., is a leading Chinese pharmaceutical manufacturer based in Jiamusi, Heilongjiang Province. A subsidiary of the publicly traded Beijing Zhongguancun Science-Tech Development Co., Ltd., the company maintains a portfolio of over 140 products across chemical drugs and Traditional Chinese Medicine (TCM). It is notably recognized as a primary domestic supplier of Tramadol Hydrochloride and the originator of the proprietary Wujia Shenghua capsules and Ciwujia injections. The company operates multiple GMP-certified production facilities focusing on therapeutic areas such as neurology, pain management, cardiovascular health, and gastroenterology. With a history spanning over 50 years, Duoduo Pharmaceutical combines large-scale industrial manufacturing with the development of patented TCM formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Duoduo Pharmaceutical.